The Bristol Oncology Podcasts

Welcome to The Bristol Oncology Podcasts. These podcasts are aimed at those training to become oncologists, providing an overview of how to treat people with cancer, through interviews with specialists in cancer care. Your host, Dr Alison Cameron, is a Clinical Oncologist based in Bristol, UK. The first series will cover the treatment of breast and ovarian cancer. For more information and referenced papers, please go to www.ace-rt.com

How I treat Oesophageal Cancer 07/20/2025

How I treat Oesophageal Cancer Dr Tom Bird, Consultant Clinical Oncologist at Bristol Haematology and Oncology Center, UK, discusses how he treats people with oesophageal cancer. This includes, locally advanced adenocarcinoma including staging, systemic and radiotherapy treatment, metastatic/recurrent adenocarcinoma (which includes an update on the treatment of gastric cancer treatment -alongside GOJ cancer -that we discussed in the prior gastric cancer podcast) including both systemic agents and palliative radiotherapy, and how treatment differs with squamous cell histology. This podcast is an overview of the current oncology treatment of oesophageal cancer at a registrar level and is aimed at those training in oncology in the UK. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/37469825

How I treat gastric cancer 02/25/2024

How I treat gastric cancer Dr Tom Bird, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with gastric cancer. We cover scenarios including both operable gastric cancer and those with recurrent and de-novo metastatic cancer including systemic agents and palliative radiotherapy. This podcast is an overview of the current oncology treatment of gastric cancer at registrar level and is aimed at those training in oncology in the UK. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/30099598

How I treat metastatic colorectal cancer 08/20/2023

How I treat metastatic colorectal cancer This is the second interview with Dr Tom Strawson-Smith, Consultant Clinical Oncologist, at Bristol Haematology and Oncology Centre, UK, concluding the overview of how to manage colorectal cancer. He discusses how he treats people who have metastatic colorectal cancer, both widely metastatic and those with oligo-metastatic disease, focusing on the use of systemic treatments. This podcast is an overview of current oncology treatment of metastatic colorectal cancer at registrar level. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/27801951

How I treat initial colorectal cancer 02/22/2023

How I treat initial colorectal cancer Dr Tom Strawson-Smith, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, UK, discusses how he treats people with initial colorectal cancer. We cover chemotherapy use in colon cancer, chemo-radiotherapy in rectal cancer including how to plan the radiotherapy, DPD deficiency and ongoing areas of research. This podcast is an overview of the current oncology treatment of intial CRC at registrar level. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/26009106

How I treat recurrent ovarian cancer 10/23/2022

How I treat recurrent ovarian cancer Dr Axel Walther, Consultant Medical Oncologist at Bristol Haematology and Oncology Centre, UK, disucsses how he treats people with recurrent ovarian cancer. He also recaps on the use of PARP inhibitors in initial advanced ovarian cancer. He is a great font of knowledge on ovarian cancer and the trials that underpin the treatment options, so this podcast will be a very useful overview of the UK current treatment paradigms at registrar level. Your host is Dr Alison Cameron, Consultant Clinical Oncologist, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/24771636

How I treat initial ovarian cancer 08/22/2022

How I treat initial ovarian cancer Dr Axel Walter, Consultant Medical Oncologist at Bristol Haematology and Oncology Center, kicks off the series about how to manage ovarian cancer. He discusses in depth the staging system and how women with initial ovarian cancer should be treated, including both those with stage 1 and stage 3 disease. This includes an explanation regarding BRCA and HRD (homologous recombination deficiency) testing and treatment with adjuvant PARP inhibitors. Your host is Dr Alison Cameron, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/24071076

How I treat metastatic triple negative breast cancer 08/16/2022

How I treat metastatic triple negative breast cancer Dr Charlie Comins, Consultant Clinical Oncologist at the Bristol Haematology and Oncology Centre, UK, joins us for the final podcast in the breast cancer series. He discusses how to treat a woman with metastatic triple negative breast cancer including use of new immunotherapies, if she was diagnosed after adjuvant chemotherapy or de novo metastatic disease. Your host is Dr Alison Cameron,Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/24068493

How I treat HER2+ metastatic breast cancer 02/14/2022

How I treat HER2+ metastatic breast cancer Dr Charlie Comins, Consultant Clinical Oncologist at Bristol Haematology and Oncology Center, UK joins us again to discuss how to manage the care of a woman with metastatic HER2+ breast cancer, including the management of her brain metastases, multiple lines of potential treatments and if she was diagnosed post adjuvant therapy, during adjuvant therapy or at inital diagnosis of breast cancer. Your host is Dr Alison Cameron, Bristol, UK. /episode/index/show/thebristoloncologypodcasts/id/22123391

How I treat ER+ metastatic breast cancer 10/03/2021

How I treat ER+ metastatic breast cancer Dr Comins, Consultant Clinical Oncologist at Bristol Haematology and Oncology Centre, specialist in breast and lung cancer, explains how he approaches the management of a woman with ER positive breast cancer, including how to treat bone metastases. /episode/index/show/thebristoloncologypodcasts/id/20686295

How I treat early breast cancer: Surgical Perspectives for Oncologists 06/18/2021

How I treat early breast cancer: Surgical Perspectives for Oncologists Interviewee today is Miss Michelle Mullan, Consultant Oncoplastic Breast Surgeon in Bristol. She provides an excellent overview of surgery for early breast cancer for an oncologist. This podcast is aimed at those training in oncology and covers surgery to the breast, axilla and for recurrence. /episode/index/show/thebristoloncologypodcasts/id/19521665

How I treat triple negative early breast cancer and impact of genetic risk factors 01/03/2021

How I treat triple negative early breast cancer and impact of genetic risk factors This is the fourth and final interview with Dr Jenner regarding the non-surgical treatment of early breast cancer. All aspects of management are covered within these four podcasts, with this final short podcast covering triple negative breast cancer, who to refer for genetic analysis and the treatment options for those who are BRCA positive. /episode/index/show/thebristoloncologypodcasts/id/17404271

How I treat early breast cancer with radiotherapy 10/31/2020

How I treat early breast cancer with radiotherapy This is the third interview with Dr Jenner, specialist in breast cancer treatment in Bristol, UK. This podcast is aimed at those training in clinical oncology and focuses on the role of radiotherapy in early breast cancer. Dr Jenner discusses the practicalities of radiotherapy planning (to the breast and local lymph nodes), the dose including the results from the fast forward study, and the rationale for radiotherapy. /episode/index/show/thebristoloncologypodcasts/id/16629569

How I treat HER-2 positive ER/PR negative early breast cancer 08/30/2020

How I treat HER-2 positive ER/PR negative early breast cancer This second interview with Dr Abi Jenner focuses on the treatment of those with HER-2 positive, ER/PR negative early breast cancer. She discusses treatment of a woman with a larger tumour requiring neo-adjuvant chemotherapy/targeted therapy, and a woman with a smaller tumour post-surgery. /episode/index/show/thebristoloncologypodcasts/id/15809186

How I treat ER/PR+, HER-2 negative breast cancer 07/08/2020

How I treat ER/PR+, HER-2 negative breast cancer Welcome to The Bristol Oncology Podcasts. These podcasts are aimed at those training to become oncologists, providing an overview of how to treat people with cancer. /episode/index/show/thebristoloncologypodcasts/id/15132668

The Bristol Oncology Podcasts

TOPICS